New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
UC Davis researchers raceed to develop coronavirus solutions
On Mar. 20, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
Humanigen announced phase III study of Coronavirus treatment planned
On Mar. 20, 2020, Humanigen announced that the company was seeking to conduct a Phase III, randomized, controlled,…
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
Abbott received FDA Emergency Use Authorization and launches test to detect novel Coronavirus
On Mar. 19, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the company’s molecular…
Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
Biotechnology | COVID-19 | FDA | Therapeutics
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
Genomic analysis showed COVID-19 coronavirus epidemic has a natural origin
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
Latest FDA guidance allows distribution of SARS-CoV-2 serology tests for diagnostic use
On Mar. 17, 2020, BioMedomics announced it will be able to distribute their COVID-19 IgM-IgG Antibody Rapid Test…
BioReference Laboratories and NYC Health + Hospitals announced collaboration to provide Coronavirus testing
On Mar. 17, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the New York City…
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
Biotechnology | COVID-19 | Diagnostics | FDA
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
Biotechnology | COVID-19 | Diagnostics | FDA
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
PathGroup launched testing for Coronavirus Disease 2019 (COVID-19)
On Mar. 16, 2020, PathGroup announced it had begun to offer testing for Coronavirus Disease 2019 (COVID-19). This…
NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
UMN Institute scientist links ancient virus to cancer risk
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
COVID-19 | Diagnostics | NIH
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…